On most people’s list of least-desirable experiences, hunting for a parking space probably falls somewhere between paying taxes and having a root canal. That may soon change, however. A half-dozen or so startups are racing to provide wireless technology that will bring parking into the age of the Internet—and in the process, reduce traffic congestion […]
As one of the forerunners in the NDDS segment, Ethypharm India, the 100 percent subsidiary of French MNC pharma major, Ethypharm SA, recently signed an out-licensing and supply contract with Ranbaxy for its product, Tramadol Flashtab. Ajey Kumar, CEO, Ethypharm India talks at length to Sonal Shukla about the NDDS market and the future plans […]
MISSISSAUGA, ON, June 15 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND)
today announced that it has received notice from the U.S. Food and Drug
Administration (FDA) that the Company will not be required to complete a Phase
I trial to investigate the potential for a clinically relevant interaction
between CIP-TRAMADOL ER, its once-daily, sustained release formulation of the
pain medication […]
By JOE GRAEDON AND TERESA GRAEDON
King Features Syndicate
In 1995, the Food and Drug Administration approved a new drug for treating osteoporosis. Fosamax was heralded as a major breakthrough.
Before this pill was introduced, there were no easy ways to combat osteoporosis. This condition weakens bones and can lead to life-threatening fractures.
During the past decade, Fosamax […]
1 130 Stephen Terrace, Gilberton, SA 5081, Australia. E-mail address: footmed@bigpond.net.au
2 174 Hancock Road, Ridgehaven, SA 5097, Australia. E-mail address: drherman@footandankle.com.au
The authors did not receive grants or outside funding in support of their research for or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide […]
Cardiovascular | Oncology | Pain & Inflammation | Central Nervous System | Infectious Disease
Article Preview
Labopharm In Belgian Distrib Pact For Tramadol
Dow Jones - May. 09, 2006
Dow Jones Newswires
Labopharm Inc. (DDSS) has signed a licensing and distribution agreement with Grunenthal GmbH for its once-daily tramadol product for Belgium.
The Laval, Que. pharmaceutical company […]
LAVAL, QC, May 31 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ:DDSS) today announced that it has granted Glaxo Group Limited (GSK) exclusive rights to distribute its once-daily tramadol product in Mexico. This agreement expands the existing licensing and distribution arrangement between Labopharm and GSK for 20 Latin American and Caribbean countries entered into in September […]
Labopharm Inc. (DDSS) has granted GlaxoSmithKline (GSK) exclusive rights to distribute its once-daily tramadol product in Mexico.
The Laval, Que. pharmaceutical company said the agreement expands the existing licensing and distribution arrangement between it and Glaxo, entered into in September 2005, for 20 Latin American and Caribbean countries.
Labopharm said it will supply Glaxo with product and […]